Comparison

GLP-1 receptor agonist 9 European Partner

Item no. HY-145458-1ea
Manufacturer MedChem Express
CASRN 2401892-71-3
Amount 1 ea
Quantity options 100 mg 10 mg 1 ea 1 mg 25 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C32H31ClFN3O5
Citations [1]Gary E. Aspnes, et al. Combinaisons comprenant du benzodioxol en tant qu'agonistes de glp-1r destinées à être utilisées dans le traitement de la nash/nafld et de maladies associées. Patent WO2020234726 A1.
Smiles C[C@@]1(C2=C(C=C(C=C2)Cl)F)OC3=C(C4CCN(CC4)CC(N(C5=C6)C[C@@H]7CCO7)=NC5=CC=C6C(O)=O)C=CC=C3O1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
GLP-1 receptor agonist 9 is a GLP-1 receptor agonist, example 7, extracted from WO2020234726 A1[1].
Shipping
Room temperature
Manufacturers Applications
Metabolism-sugar/lipid metabolism
MolecularWeight
592.06
Clinical Information
No Development Reported
Manufacturers Research Area
Metabolic Disease
Solubility
10 mM in DMSO
Target
GCGR
Manufacturers Target
GCGR
Manufacturers Pathway
GPCR/G Protein
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close